Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Pediatric Nephrology (Berlin, Germany)|January 26, 2023
Pharmacokinetic profile of acyclovir in a child receiving continuous kidney replacement therapy for acute liver failureCharlotte Collignon, Charles de Marcellus, Mehdi Oualha, et al.
The Pediatric Infectious Disease Journal|March 12, 2021
Nevirapine Pharmacokinetics in Neonates Between 25 and 32 Weeks Gestational Age for the Prevention of Mother-to-Child Transmission of HIVDéborah Hirt, Jean Kubota Kilengelela, Pierre-Henri Jarreau, et al.
Current Pharmaceutical Design|March 21, 2019
Methodological Approaches to Evaluate Fetal Drug ExposureNaïm Bouazza, Frantz Foissac, Déborah Hirt, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Developmental pharmacokinetics of lamivudine in 580 pediatric patients ranging from neonates to adolescentsNaïm Bouazza, Déborah Hirt, Stéphane Blanche, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2011
Pharmacokinetics and virological efficacy after switch to once-daily lopinavir-ritonavir in treatment-experienced HIV-1-infected childrenFrantz Foissac, Saïk Urien, Déborah Hirt, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2014
Population pharmacokinetics of abacavir in pregnant womenFloris Fauchet, Jean-Marc Treluyer, Laure-Helene Préta, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 17, 2009
Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in ratsDéborah Hirt, Julien Fonsart, Marie-Claude Menet, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Age-related effects on nelfinavir and M8 pharmacokinetics: a population study with 182 childrenDéborah Hirt, Saïk Urien, Vincent Jullien, et al.
Pageof 8